CSIMarket Company Name, Ticker, Suppliers, else..
 
Novan Inc   (NASDAQ: NOVN)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 26
 Employees 37
 Revenues (TTM) (Millions $) 25
 Net Income (TTM) (Millions $) -32
 Cash Flow (TTM) (Millions $) -22
 Capital Exp. (TTM) (Millions $) 3

Novan Inc
Novan Inc is a biotechnology company that specializes in the development and commercialization of innovative therapies for dermatological conditions. The company focuses on leveraging nitric oxide's natural antimicrobial and anti-inflammatory properties to create novel and differentiated products for various skin conditions.

Novan's proprietary technology platform, known as Nitricil, harnesses the power of nitric oxide to penetrate and disrupt biofilms in the skin, which can often lead to chronic and treatment-resistant infections. This technology has potential applications in areas such as acne, warts, onychomycosis (nail fungal infections), and molluscum contagiosum.

The company's lead product candidate, SB206, is being developed for the treatment of molluscum contagiosum, a common skin viral infection that primarily affects children. Novan has also ventured into the development of nitric oxide-based therapies for other indications, including genital warts and inflammatory skin diseases like psoriasis.

Novan Inc has formed partnerships with various organizations to support the development and marketing of its products. The company has a collaborative agreement with Sato Pharmaceutical for the development and commercialization of SB204 and SB206 products in Japan. Novan is also engaged in preclinical research and development projects to explore the therapeutic potential of its Nitricil platform in other indications.

Overall, Novan Inc is a biotechnology company striving to bring innovative and effective therapies to patients with dermatological conditions by utilizing the unique properties of nitric oxide.


   Company Address: 4020 Stirrup Creek Drive, Suite 110 Durham, 27703 NC
   Company Phone Number: 485-8080   Stock Exchange / Ticker: NASDAQ NOVN


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABBV   -2.93%    
BMY        1.68% 
LLY   -9%    
MRK   -3.03%    
PFE   -1.87%    
VTRS   -4.24%    
• View Complete Report
   



Novan Inc

First Quarter of 2023 Reveals Impressive Growth, Indicating Advancement in Disruptive Therapies within Dermatological Medical Field

Novan Inc: Overview
Novan Inc. is a clinical-stage biotechnology company that operates in the United States. The company is primarily involved in the development and commercialization of innovative therapies designed to address unmet medical needs in the healthcare industry. Novan utilizes its proprietary Nitricil technology platform to develop various topical formulations for the treatment of dermatological medical conditions such as warts, atopic dermatitis, psoriasis, and acne.
The firm aims to develop differentiated solutions to disrupt the current standard of care within the therapeutic areas. Novan's Nitricil technology leverages a unique mechanism of action for sustained topical delivery of nitric oxide (NO) into the skin. Nitric oxide is known for its antimicrobial, anti-inflammatory, and vasodilatory properties, making it a promising solution for targeting various dermatological conditions.









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com